English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/169203
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma

AuthorsGalicia, N.; Dégano, Rosa M.; Díez, Paula; González González, María; Góngora, Rafael; Ibarrola, Nieves ; Fuentes, Manuel
KeywordsLeptomeningeal lymphoma
Cerebrospinal fluid
Issue Date2017
PublisherTaylor & Francis
CitationExpert Review of Proteomics 14(4): 363-372 (2017)
Abstract[Introduction]: Leptomeningeal metastases (LM) from lymphoma remain a difficult complication for oncologist due to the high incidence in morbidity and mortality. Early diagnostic and initiation of treatment are essential to prevent neurological deterioration. [Areas covered]: In this review, several proteomic approaches are described in order to help and provide the basis for the identification of biomarkers useful in early diagnosis, also in discovery novel targets for therapeutic agents. In fact, the identification of biomarkers will have a high potential to detect leptomeningeal lymphoma, as well as to predict its progression and treatment response. [Expert commentary]: In the case of LM by Central nervous system (CNS) lymphoma, these studies generated the first insights into the utility of proteomic analysis for biomarker identification and will be demonstrated that identifying specific proteins in cerebrospinal fluid (CSF) had much greater sensitivity for detecting LM in comparison to standard cytological protocols.
Identifiersdoi: 10.1080/14789450.2017.1307106
e-issn: 1744-8387
issn: 1478-9450
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.